Pharmacology proctored exam
Ramelteon is a MT1/MT2 agonist marketed for insomnia, and tasimelteon, another MT1/MT2 agonist, is marketed for non-24-hour sleep-wake disorder. These agents help to improve what process of sleep?
Sign in to reveal the correct answer & rationale
A free account unlocks answers for the preview questions in every exam. A pass unlocks all of them.
Your Progress
Correct0
Incorrect0
Skipped0
Accuracy0%